The National Healthcare Security Administration is publicly soliciting opinions on the "Guidelines for the Comprehensive Value Evaluation of Drugs in Real-World Healthcare Insurance (Trial)"

On January 14th, the National Healthcare Security Administration issued an announcement to accelerate the establishment of a nationwide unified real-world comprehensive value evaluation system for drug insurance. In accordance with the requirements of the "Notice on the Pilot Work for Real-World Comprehensive Value Evaluation of Medical Insurance" (Medical Insurance Office Document [2025] No. 15), the Drug Price and Bidding Procurement Guidance Center of the National Healthcare Security Administration has drafted the "Guidelines for Real-World Comprehensive Value Evaluation of Drugs (Trial)," which is now open for public consultation